{"filing":{"accession_number":"0001299130-26-000092","cik":"0001299130","ticker":"PACB","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"pacb-20260603.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/pacb-20260603.htm"},"events":[{"id":6869,"run_id":6018,"accession_number":"0001299130-26-000092","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Pacific Biosciences held its Annual Meeting of Stockholders on June 3, 2026, with shareholders voting on four proposals: election of four Class III directors, ratification of Ernst \u0026 Young LLP as independent auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2020 Equity Incentive Plan reserving an additional 16,000,000 shares. Detailed vote tallies for each proposal were disclosed.","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","ticker":"PACB","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4408,"accession_number":"0001299130-26-000092","item_number":"5.02","item_title":"DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on board approval and stockholder ratification of an amendment to the 2020 Equity Incentive Plan reserving an additional 16,000,000 shares for issuance. This is a compensatory arrangement affecting equity grants available to officers and directors, falling squarely within the exec_compensation category. The materiality is high given the substantial share reserve increase and stockholder vote required.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:17:53.298212+00:00","company_name":"","ticker":null,"filing_date":""},{"id":4409,"accession_number":"0001299130-26-000092","item_number":"5.07","item_title":"SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from the Annual Meeting held on June 3, 2026, covering four proposals: election of four Class III directors, ratification of Ernst \u0026 Young LLP as independent auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2020 Equity Incentive Plan. The filing presents detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:17:53.298212+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4408,"accession_number":"0001299130-26-000092","item_number":"5.02","item_title":"DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on board approval and stockholder ratification of an amendment to the 2020 Equity Incentive Plan reserving an additional 16,000,000 shares for issuance. This is a compensatory arrangement affecting equity grants available to officers and directors, falling squarely within the exec_compensation category. The materiality is high given the substantial share reserve increase and stockholder vote required.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:17:53.298212+00:00","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","ticker":"PACB","filing_date":"2026-06-04"},{"id":4409,"accession_number":"0001299130-26-000092","item_number":"5.07","item_title":"SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from the Annual Meeting held on June 3, 2026, covering four proposals: election of four Class III directors, ratification of Ernst \u0026 Young LLP as independent auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2020 Equity Incentive Plan. The filing presents detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:17:53.298212+00:00","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","ticker":"PACB","filing_date":"2026-06-04"}]}